Search - tctmd.com

Displaying 1 - 20 of 38

Sort: Relevancy | Date

News Daily News

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

L.A. McKeown

December 07, 2020

News Conference News AHA 2020

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

L.A. McKeown

November 18, 2020

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Conference News AHA 2020

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

Todd Neale

November 16, 2020

News Conference News AHA 2020

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Todd Neale

November 13, 2020

News Daily News

Heart Failure Doubles Risk of Dying From COVID-19

L.A. McKeown

October 30, 2020

News Daily News

More Than Half of All HF Patients Take 10 or More Meds

L.A. McKeown

October 20, 2020

News Conference News HFSA 2020

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

L.A. McKeown

October 12, 2020

News Conference News HFSA 2020

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

L.A. McKeown

October 09, 2020

More HF Readmissions Among Black People From Deprived Neighborhoods

News Conference News HFSA 2020

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Michael O'Riordan

September 30, 2020

News Daily News

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

Shelley Wood

September 30, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Shelley Wood

September 22, 2020

News Conference News ESC 2020

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

Michael O'Riordan

August 31, 2020

News Conference News ESC 2020

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

Todd Neale

August 30, 2020

News Conference News ESC 2020

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

Michael O'Riordan

August 29, 2020

News Conference News ESC 2020

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

Michael O'Riordan

August 28, 2020

News Daily News

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Michael O'Riordan

August 26, 2020

Advertisement

Fracking, Other Natural Gas Activity Linked to Hospitalizations for HF Patients

Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

Empagliflozin Improves Cardiac Function, Exercise Capacity in Nondiabetic HFrEF

Modest Gains With Omecamtiv Mecarbil in Chronic HFrEF: GALACTIC-HF

Heart Failure Doubles Risk of Dying From COVID-19

More Than Half of All HF Patients Take 10 or More Meds

Splanchnic Nerve Ablation Improves HFpEF Symptoms, QoL in FIH Study

EMBRACE HF: Empagliflozin Cuts PA Pressure in HF With or Without Diabetes

More HF Readmissions Among Black People From Deprived Neighborhoods

TAVR Delays During Pandemic’s Peak Led to Hospitalizations, Deaths

Fewer MACE in Diabetic Patients Taking SGLT2 Inhibitors vs DPP-4 Inhibitors

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Recurrent Events After MI Show Enduring Gender, Racial Gaps in Care

Revascularization Benefits ISCHEMIA Patients With Mild LV Dysfunction or HF

PARALLAX: Mixed Results for Sacubitril/Valsartan in HFpEF

EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class

EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF

‘Message Unchanged,’ Say Researchers of Criticized COVID-19 CMR Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content